This study describes the distribution of clinical and metabolic characteristics among a large cohort of children with NAFLD stratified by receipt of biopsy (biopsy, no biopsy) and peak ALT level (≤70 U/L, >70–≤250 U/L, and >250 U/L). This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.